Privia Health Group Inc.
Privia Health Group, Inc. operates as a physician practice management and population health technology company in the United States. The company comprises regional medical groups, accountable care organizations, and specialty verticals. It offers technology and population health tools to enhance independent providers' workflows; management service organization that enables providers to reduce administrative work focus on their patients; single-TIN medical group that facilitates payer negotiation, clinical integration and alignment of financial incentives; physician-led accountable care organization, which engages patients, reduces inappropriate utilization, and enhances coordination and patient quality metrics to drive value-based care and transform the healthcare delivery system; and network for purchasers and payers. The company was founded in 2007 and is headquartered in Arlington, Virginia. Privia Health Group, Inc. operates as a subsidiary of Brighton Health Group Holdings, LLC.
IPO Year: 2021
Exchange: NASDAQ
Website: priviahealth.com
Recent Analyst Ratings for Privia Health Group Inc.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 1/10/2025 | $25.00 | Buy | Needham |
| 12/16/2024 | Outperform | Macquarie | |
| 10/11/2024 | $23.00 | Overweight | KeyBanc Capital Markets |
| 5/30/2024 | $23.00 | Outperform | Robert W. Baird |
| 4/22/2024 | $25.00 | Buy | Citigroup |
| 3/6/2024 | $22.00 | Equal Weight | Barclays |
| 2/26/2024 | $33.00 → $25.00 | Buy | Jefferies |
| 2/22/2024 | $21.00 | Buy → Neutral | BofA Securities |
| 12/6/2023 | $27.00 | Mkt Outperform | JMP Securities |
| 6/13/2023 | $34.00 | Outperform | Evercore ISI |
Privia Health Group Inc. Press Releases
Fastest customizable press release news feed in the world
Privia Health Reports Fourth Quarter and Full-Year 2024 Financial Results
All 2024 Operating and Financial Metrics Above High End of Guidance RangesVery strong New Provider Signings with Implemented Providers +11.2% from Year-end 2023Full-year 2024 Net Cash Provided by Operating Activities of $109.3 million, +35.3% from 2023, with De Minimis Capital ExpendituresYear-end 2024 Cash Balance of $491.1 million and No Debt2025 Guidance Reflects Continued Momentum and Profitable Growth Despite Challenging Medicare Advantage and Value-based Environment ARLINGTON, Va., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced financial and operating results for the fourth quarter and full year ended December 31, 2024. Each of the Company'
Privia Health to Report Fourth Quarter 2024 Results on Thursday, February 27
ARLINGTON, Va., Jan. 24, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced that it expects to release financial results for its fourth quarter and full-year periods ended December 31, 2024 before market open on Thursday, February 27, 2025. The press release is expected to be publicly disseminated by 7:00 am ET and will also be available on the Company's Investor Relations website at ir.priviahealth.com. Privia Health management will host a conference call beginning at 8:00 am ET on the same day, Thursday, February 27, to discuss the results and management's outlook for future financial and operational performance. You can visit ir.priviahealth.com/news-
Privia Health Reports Third Quarter 2024 Financial Results
Strong Execution Across All Business and Financial MetricsRaised Full-Year 2024 Guidance to At or Above the High End for All MetricsAnnounced New Market Entry in Indiana Achieved MSSP 2023 Shared Saving of $176.6 Million, +34.1% versus 2023Strong Adjusted EBITDA Growth and Free Cash Flow Generation ARLINGTON, Va., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced financial results for the third quarter and nine months ended September 30, 2024. Third Quarter Performance For the Three Months Ended September 30, ($ in millions, except per share amounts) 2024 2023 Change (%) Total revenue $437.9 $417.3 4.9%Gross profit $99.9 $90.6 10
Privia Health Reports 2023 Performance Results in the Medicare Shared Savings Program
ARLINGTON, Va., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced that its Accountable Care Organizations (ACOs) achieved shared savings of $176.6 million through the Medicare Shared Savings Program (MSSP) for the 2023 performance year, a 34.1% increase from 2022. The 10 ACOs (collectively, Privia Quality Network or PQN) managed over $2.3 billion in healthcare benchmark spend through approximately 2,850 providers delivering high-value, cost-efficient care to 194,786 Medicare beneficiaries in 2023. "The success of Privia Quality Network in MSSP is a testament to the dedication and skill of our doctors, who provided exceptional care to nearly 195,000
Privia Health to Report Third Quarter 2024 Results on Thursday, November 7
ARLINGTON, Va., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced that it expects to release financial results for its third quarter and nine-month periods ended September 30, 2024 before market open on Thursday, November 7, 2024. The press release is expected to be publicly disseminated by 7:00 am ET and will also be available on the Company's Investor Relations website at ir.priviahealth.com. Privia Health management will host a conference call beginning at 8:00 am ET on the same day, Thursday, November 7, to discuss the results and management's outlook for future financial and operational performance. You can visit ir.priviahealth.com/news-and-e
Privia Health Reports Second Quarter 2024 Financial Results
Strong Execution Across All Business and Financial MetricsRaised Full-Year 2024 Guidance to Mid to High End for All Metrics ARLINGTON, Va., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced financial results for the second quarter and six months ended June 30, 2024. Second Quarter Performance For the Three Months Ended June 30, ($ in millions, except per share amounts) 2024 2023 Change (%) Total revenue $422.3 $413.4 2.2%Gross profit $98.3 $90.2 8.9%Operating income $5.1 $7.0 (27.0)%Net income a $3.5 $7.3 (52.3)%Non-GAAP adjusted net income b $23.5 $20.8 13.0%Net income per share $0.03 $0.06 (50.0)%Non-GAAP adjusted net income per sh
Privia Health to Report Second Quarter 2024 Results on Thursday, August 8
ARLINGTON, Va., July 11, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced that it plans to release financial results for its second quarter and six-month periods ended June 30, 2024 before market open on Thursday, August 8, 2024. The press release is expected to be publicly disseminated by 7:00 am ET and will also be available on the Company's Investor Relations website at ir.priviahealth.com. Privia Health management will host a conference call beginning at 8:00 am ET on the same day, Thursday, August 8, to discuss the results and management's outlook for future financial and operational performance. You can visit ir.priviahealth.com/news-and-events/event
Privia Receives HFMA's MAP Award for High Performance in Revenue Cycle for Performance Year 2023
ARLINGTON, Va., June 25, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) announced that its network of affiliated medical groups, collectively Privia Medical Group, has been named a recipient of the 2024 MAP Award for High Performance in Revenue Cycle, sponsored by the Healthcare Financial Management Association (HFMA). Privia has been recognized by HFMA for its revenue cycle capabilities and performance in eight of the last nine years. As a national award winner, Privia has met industry-standard revenue cycle benchmarks, implemented the patient-centered recommendations and best practices embodied in HFMA's Healthcare Dollars & Sense® initiatives, and achieved outstandi
Privia Health to Participate in the William Blair Growth Stock Conference
ARLINGTON, Va., May 30, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced that its management team plans to present at the 44th Annual William Blair Growth Stock Conference on Wednesday, June 5, 2024, beginning at 11:00 am ET / 10:00 am CT. The live webcast and replay of the event will be available at ir.priviahealth.com/news-and-events/events-and-presentations. About Privia Health Privia Health™ is a technology-driven, national physician enablement company that collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-p
Privia Health Reports First Quarter 2024 Financial Results
Practice Collections +7.4% compared to 1Q'23Implemented Providers +17.3% compared to 1Q'23Company Reiterated Full Year 2024 Guidance ARLINGTON, Va., May 09, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced financial results for the first quarter ended March 31, 2024. For the Three Months Ended March 31, ($ in millions, except per share amounts) 2024 2023 Change (%) Total revenue$ 415.2 $ 386.3 7.5 %Gross profit$ 93.4 $ 83.0 12.5 %Operating income$ 0.8 $ 6.7 (87.7)%Net income a$ 3.0 $ 7.3 (59.3)%Non-GAAP adjusted net income b$ 22.5 $
Privia Health Group Inc. Analyst Ratings
Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.
Needham initiated coverage on Privia Health with a new price target
Needham initiated coverage of Privia Health with a rating of Buy and set a new price target of $25.00
Macquarie initiated coverage on Privia Health
Macquarie initiated coverage of Privia Health with a rating of Outperform
KeyBanc Capital Markets initiated coverage on Privia Health with a new price target
KeyBanc Capital Markets initiated coverage of Privia Health with a rating of Overweight and set a new price target of $23.00
Robert W. Baird initiated coverage on Privia Health with a new price target
Robert W. Baird initiated coverage of Privia Health with a rating of Outperform and set a new price target of $23.00
Citigroup initiated coverage on Privia Health with a new price target
Citigroup initiated coverage of Privia Health with a rating of Buy and set a new price target of $25.00
Barclays initiated coverage on Privia Health with a new price target
Barclays initiated coverage of Privia Health with a rating of Equal Weight and set a new price target of $22.00
Jefferies resumed coverage on Privia Health with a new price target
Jefferies resumed coverage of Privia Health with a rating of Buy and set a new price target of $25.00 from $33.00 previously
Privia Health downgraded by BofA Securities with a new price target
BofA Securities downgraded Privia Health from Buy to Neutral and set a new price target of $21.00
JMP Securities initiated coverage on Privia Health with a new price target
JMP Securities initiated coverage of Privia Health with a rating of Mkt Outperform and set a new price target of $27.00
Evercore ISI initiated coverage on Privia Health with a new price target
Evercore ISI initiated coverage of Privia Health with a rating of Outperform and set a new price target of $34.00
Privia Health Group Inc. Insider Purchases
Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.
Director Boehler Adam bought $6,006 worth of shares (364 units at $16.50) (SEC Form 4)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
Boehler Adam bought $87,549 worth of shares (5,306 units at $16.50) (SEC Form 4)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
Boehler Adam bought $70,577 worth of shares (4,280 units at $16.49) (SEC Form 4)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
Mccarthy Thomas A was granted 11,124 shares and bought $163,700 worth of shares (10,000 units at $16.37), increasing direct ownership by 67% to 52,611 units (SEC Form 4)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
Boehler Adam bought $8,978,460 worth of shares (552,436 units at $16.25) (SEC Form 4)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
Privia Health Group Inc. Insider Trading
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
Chief Executive Officer Mehrotra Parth sold $252,651 worth of shares (10,514 units at $24.03), decreasing direct ownership by 2% to 469,381 units (SEC Form 4)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
Chief Executive Officer Mehrotra Parth sold $458,410 worth of shares (18,934 units at $24.21), decreasing direct ownership by 4% to 479,895 units (SEC Form 4)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
EVP & Chief Financial Officer Mountcastle David sold $141,658 worth of shares (5,851 units at $24.21), decreasing direct ownership by 3% to 185,306 units (SEC Form 4)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
EVP & General Counsel Fargis Edward C sold $120,256 worth of shares (4,967 units at $24.21), decreasing direct ownership by 5% to 93,054 units (SEC Form 4)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
EVP & General Counsel Fargis Edward C was granted 25,073 shares, increasing direct ownership by 34% to 98,021 units (SEC Form 4)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
EVP & Chief Financial Officer Mountcastle David was granted 33,430 shares, increasing direct ownership by 21% to 191,157 units (SEC Form 4)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
Chief Executive Officer Mehrotra Parth was granted 133,723 shares, increasing direct ownership by 37% to 498,829 units (SEC Form 4)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
EVP & Chief Financial Officer Mountcastle David sold $2,515,000 worth of shares (100,000 units at $25.15), decreasing direct ownership by 39% to 157,727 units (SEC Form 4)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
Chief Executive Officer Mehrotra Parth exercised 252,477 shares at a strike of $2.00 and sold $2,500,127 worth of shares (135,142 units at $18.50), increasing direct ownership by 47% to 365,106 units (SEC Form 4)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
Director Morris Matthew Shawn gifted 11,998 shares and received a gift of 11,998 shares (SEC Form 4)
4 - Privia Health Group, Inc. (0001759655) (Issuer)
Privia Health Group Inc. SEC Filings
SEC Form 144 filed by Privia Health Group Inc.
144 - Privia Health Group, Inc. (0001759655) (Subject)
SEC Form 144 filed by Privia Health Group Inc.
144 - Privia Health Group, Inc. (0001759655) (Subject)
Privia Health Group Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
8-K - Privia Health Group, Inc. (0001759655) (Filer)
SEC Form 10-K filed by Privia Health Group Inc.
10-K - Privia Health Group, Inc. (0001759655) (Filer)
Privia Health Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
8-K - Privia Health Group, Inc. (0001759655) (Filer)
Privia Health Group Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
8-K - Privia Health Group, Inc. (0001759655) (Filer)
SEC Form S-8 filed by Privia Health Group Inc.
S-8 - Privia Health Group, Inc. (0001759655) (Filer)
SEC Form 10-Q filed by Privia Health Group Inc.
10-Q - Privia Health Group, Inc. (0001759655) (Filer)
Privia Health Group Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
8-K - Privia Health Group, Inc. (0001759655) (Filer)
SEC Form 10-Q filed by Privia Health Group Inc.
10-Q - Privia Health Group, Inc. (0001759655) (Filer)
Privia Health Group Inc. Leadership Updates
Live Leadership Updates
Privia Health Appoints Edward C. Fargis as General Counsel
ARLINGTON, Va., Jan. 29, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) announced that Edward C. Fargis has been named Executive Vice President, General Counsel and Corporate Secretary, effective today. Mr. Fargis will serve as the Company's chief legal officer, working with Privia executive leadership to support the Company's long-term direction and growth. "Ed is a proven leader who brings an invaluable healthcare industry perspective as well as extensive experience managing corporate governance, compliance and strategic transactions," said Parth Mehrotra, CEO, Privia Health. "As Privia continues to grow and our industry evolves, we are fortunate to have Ed joining us
Privia Health Announces Leadership Succession
ARLINGTON, Va., April 12, 2023 (GLOBE NEWSWIRE) -- Privia Health (NASDAQ:PRVA), a technology-driven, national physician enablement company, today announced that Parth Mehrotra, currently the Company's President and Chief Operating Officer, has been named Chief Executive Officer, effective July 1, 2023. Mehrotra is succeeding current CEO, Shawn Morris, who is retiring and will remain on the Company's Board of Directors. Under Morris' leadership since early 2018, Privia Health progressed from a private, regional organization into a publicly-traded company with national reach. During that time, the Company entered eight new states, completed a successful IPO in April 2021, and increased it
Privia Health Group Inc. Financials
Live finance-specific insights
Privia Health Reports Fourth Quarter and Full-Year 2024 Financial Results
All 2024 Operating and Financial Metrics Above High End of Guidance RangesVery strong New Provider Signings with Implemented Providers +11.2% from Year-end 2023Full-year 2024 Net Cash Provided by Operating Activities of $109.3 million, +35.3% from 2023, with De Minimis Capital ExpendituresYear-end 2024 Cash Balance of $491.1 million and No Debt2025 Guidance Reflects Continued Momentum and Profitable Growth Despite Challenging Medicare Advantage and Value-based Environment ARLINGTON, Va., Feb. 27, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced financial and operating results for the fourth quarter and full year ended December 31, 2024. Each of the Company'
Privia Health to Report Fourth Quarter 2024 Results on Thursday, February 27
ARLINGTON, Va., Jan. 24, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced that it expects to release financial results for its fourth quarter and full-year periods ended December 31, 2024 before market open on Thursday, February 27, 2025. The press release is expected to be publicly disseminated by 7:00 am ET and will also be available on the Company's Investor Relations website at ir.priviahealth.com. Privia Health management will host a conference call beginning at 8:00 am ET on the same day, Thursday, February 27, to discuss the results and management's outlook for future financial and operational performance. You can visit ir.priviahealth.com/news-
Privia Health Reports Third Quarter 2024 Financial Results
Strong Execution Across All Business and Financial MetricsRaised Full-Year 2024 Guidance to At or Above the High End for All MetricsAnnounced New Market Entry in Indiana Achieved MSSP 2023 Shared Saving of $176.6 Million, +34.1% versus 2023Strong Adjusted EBITDA Growth and Free Cash Flow Generation ARLINGTON, Va., Nov. 07, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced financial results for the third quarter and nine months ended September 30, 2024. Third Quarter Performance For the Three Months Ended September 30, ($ in millions, except per share amounts) 2024 2023 Change (%) Total revenue $437.9 $417.3 4.9%Gross profit $99.9 $90.6 10
Privia Health to Report Third Quarter 2024 Results on Thursday, November 7
ARLINGTON, Va., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced that it expects to release financial results for its third quarter and nine-month periods ended September 30, 2024 before market open on Thursday, November 7, 2024. The press release is expected to be publicly disseminated by 7:00 am ET and will also be available on the Company's Investor Relations website at ir.priviahealth.com. Privia Health management will host a conference call beginning at 8:00 am ET on the same day, Thursday, November 7, to discuss the results and management's outlook for future financial and operational performance. You can visit ir.priviahealth.com/news-and-e
Privia Health Reports Second Quarter 2024 Financial Results
Strong Execution Across All Business and Financial MetricsRaised Full-Year 2024 Guidance to Mid to High End for All Metrics ARLINGTON, Va., Aug. 08, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced financial results for the second quarter and six months ended June 30, 2024. Second Quarter Performance For the Three Months Ended June 30, ($ in millions, except per share amounts) 2024 2023 Change (%) Total revenue $422.3 $413.4 2.2%Gross profit $98.3 $90.2 8.9%Operating income $5.1 $7.0 (27.0)%Net income a $3.5 $7.3 (52.3)%Non-GAAP adjusted net income b $23.5 $20.8 13.0%Net income per share $0.03 $0.06 (50.0)%Non-GAAP adjusted net income per sh
Privia Health to Report Second Quarter 2024 Results on Thursday, August 8
ARLINGTON, Va., July 11, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced that it plans to release financial results for its second quarter and six-month periods ended June 30, 2024 before market open on Thursday, August 8, 2024. The press release is expected to be publicly disseminated by 7:00 am ET and will also be available on the Company's Investor Relations website at ir.priviahealth.com. Privia Health management will host a conference call beginning at 8:00 am ET on the same day, Thursday, August 8, to discuss the results and management's outlook for future financial and operational performance. You can visit ir.priviahealth.com/news-and-events/event
Privia Health Reports First Quarter 2024 Financial Results
Practice Collections +7.4% compared to 1Q'23Implemented Providers +17.3% compared to 1Q'23Company Reiterated Full Year 2024 Guidance ARLINGTON, Va., May 09, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced financial results for the first quarter ended March 31, 2024. For the Three Months Ended March 31, ($ in millions, except per share amounts) 2024 2023 Change (%) Total revenue$ 415.2 $ 386.3 7.5 %Gross profit$ 93.4 $ 83.0 12.5 %Operating income$ 0.8 $ 6.7 (87.7)%Net income a$ 3.0 $ 7.3 (59.3)%Non-GAAP adjusted net income b$ 22.5 $
Privia Health to Report First Quarter 2024 Results on Thursday, May 9
ARLINGTON, Va., April 09, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced that it plans to release financial results for its first quarter ended March 31, 2024 before market open on Thursday, May 9, 2024. The press release is expected to be publicly disseminated by 7:00 am ET and will also be available on the Company's Investor Relations website at ir.priviahealth.com. Privia Health management will host a conference call beginning at 8:00 am ET on the same day, Thursday, May 9, to discuss the results and management's outlook for future financial and operational performance. You can visit ir.priviahealth.com/news-and-events/events-and-presentations to list
Privia Health Reports Fourth Quarter and Full-Year 2023 Financial Results
Achieved All 2023 Operating and Financial Guidance MetricsImplemented Providers +19.4% compared to Year-End 2022Introduces Full-Year 2024 GuidanceProactive Steps to Limit Downside Risk Arrangements in Current Medicare Advantage Environment for More Favorable Contract Structures and Margin Contribution ARLINGTON, Va., Feb. 27, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced financial and operating results for the fourth quarter and full year ended December 31, 2023. The Company achieved each of its full-year guidance metrics for 2023, as highlighted below. Full-Year Performance For the Years Ended December 31, ($ in millions, except per sh
Privia Health to Report Fourth Quarter and Full-Year 2023 Results on Tuesday, February 27
ARLINGTON, Va., Jan. 23, 2024 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (NASDAQ:PRVA) today announced that it plans to release financial results for its fourth quarter and full year ended December 31, 2023 before market open on Tuesday, February 27, 2024. The press release is expected to be publicly disseminated by 7:00 am ET and will also be available on the Company's Investor Relations website at ir.priviahealth.com. Privia Health management will host a conference call beginning at 8:00 am ET on the same day, Tuesday, February 27, to discuss the results and management's outlook for future financial and operational performance. You can visit ir.priviahealth.com/news-and-events/event
Privia Health Group Inc. Large Ownership Changes
This live feed shows all institutional transactions in real time.
Amendment: SEC Form SC 13G/A filed by Privia Health Group Inc.
SC 13G/A - Privia Health Group, Inc. (0001759655) (Subject)
Amendment: SEC Form SC 13G/A filed by Privia Health Group Inc.
SC 13G/A - Privia Health Group, Inc. (0001759655) (Subject)
Amendment: SEC Form SC 13G/A filed by Privia Health Group Inc.
SC 13G/A - Privia Health Group, Inc. (0001759655) (Subject)
SEC Form SC 13G filed by Privia Health Group Inc.
SC 13G - Privia Health Group, Inc. (0001759655) (Subject)
SEC Form SC 13G/A filed by Privia Health Group Inc. (Amendment)
SC 13G/A - Privia Health Group, Inc. (0001759655) (Subject)
SEC Form SC 13G/A filed by Privia Health Group Inc. (Amendment)
SC 13G/A - Privia Health Group, Inc. (0001759655) (Subject)
SEC Form SC 13G/A filed by Privia Health Group Inc. (Amendment)
SC 13G/A - Privia Health Group, Inc. (0001759655) (Subject)
SEC Form SC 13G filed by Privia Health Group Inc.
SC 13G - Privia Health Group, Inc. (0001759655) (Subject)
SEC Form SC 13G filed by Privia Health Group Inc.
SC 13G - Privia Health Group, Inc. (0001759655) (Subject)
SEC Form SC 13G filed by Privia Health Group Inc.
SC 13G - Privia Health Group, Inc. (0001759655) (Subject)